<DOC>
	<DOCNO>NCT00965380</DOCNO>
	<brief_summary>The purpose study utilize Trinity Evolution conjunction interbody spacer supplemental posterior fixation surgeon 's choice follow patient measure clinical outcome rate fusion . The hypothesis study Trinity Evolution combine interbody spacer supplemental posterior fixation result fusion rate clinical outcome similar routinely use autograft allograft material include : fusion , improvement pain function , maintenance low extremity neurological function , absence serious adverse event relate use Trinity Evolution product .</brief_summary>
	<brief_title>Trinity Evolution Posterior Transforaminal Lumbar Interbody Fusion ( PLIF/TLIF )</brief_title>
	<detailed_description>Degenerative disorder lumbar spine lead multitude clinical problem include back pain and/or leg pain secondary nerve compression and/or deformity . When conservative ( non-surgical ) treatment fail least 6 month period and/or non-operative treatment indicate , patient physician may turn surgical solution . Surgical option consist basically decompress nerve , correct and/or stabilize deformity require fuse segment , depend clinical situation . The `` gold standard '' aid heal spinal fusion surgery harvest autograft patient 's iliac crest place around segment spine intend fuse . Autograft consider `` gold standard '' contain essential element require successful bone grafting : osteogenesis , osteoconduction , osteoinduction . However , morbidity harvesting autograft well document include chronic donor-site pain , infection , neurologic injury , blood loss , deformity , bowel injury , hernia , prolong surgical hospitalization time . There number product market minimize replace use autograft . However , product contain three essential bone-forming element ( osteogenesis , osteoconduction , osteoinduction ) single , stand alone product . Trinity Evolution novel , allogeneic cancellous bone matrix contain viable osteoprogenitor cell , mesenchymal stem cell demineralized cortical bone ( DCB ) component provide require osteoconduction , osteogenesis , osteoinduction necessary successful bone grafting . Preclinical study Trinity Evolution demonstrate in-vitro in-vivo safety effectiveness . Trinity Evolution consider allograft `` minimally manipulate '' tissue label bone repair spinal , orthopedic podiatric indication autograft use . The dosage dependent upon specific requirement case .</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Symptomatic lumbar degenerative disc disease 1 2 adjacent level L3 S1 Patients back and/or leg pain schedule stabilization without decompression via TLIF PLIF approach utilize interbody spacer supplemental posterior fixation . Greater 18 year age Unresponsive conservative care period least 6 month progressive neurological sign and/or symptom neurological compromise mandate urgent surgical intervention Willing able comply requirement protocol include followup requirement Willing able sign study specific informed consent . Patients require surgical treatment 1 2 adjacent level L3 S1 Active local systemic infection Currently pregnant consider become pregnant followup period Active malignancy chemotherapy kind malignancy past 1 year Use bone graft bone graft substitute addition place Trinity Evolution matrix around interbody spacer . Use adjunctive postoperative stimulation Prior interbody surgery level Has know history hypersensitivity anaphylactic reaction dimethyl sulfoxide ( DMSO ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Trinity Evolution</keyword>
	<keyword>Symptomatic lumbar degenerative disc disease</keyword>
	<keyword>Posterior lumbar interbody fusion</keyword>
	<keyword>Transforaminal lumbar interbody fusion</keyword>
</DOC>